New Delhi, XX November 2024 – Informa Markets in India announced the 17th edition of the CPHI & PMEC India Expo, South Asia’s largest and most prestigious pharmaceutical industry event. The three-day expo is set to take place from November 26th to November 28th, 2024, at the India Expo Centre, Greater Noida. This renowned platform will unite the Indian and South Asian pharmaceutical sectors, offering an unparalleled opportunity for networking, showcasing innovations, and driving industry growth.
The CPHI & PMEC India Expo 2024 promises to be a transformative event for the pharmaceutical sector, bringing together over 50,000 industry professionals and 2,000 exhibitors, who will present more than 10,000 innovative products. The expo will showcase advancements across the pharmaceutical value chain, facilitating high-value partnerships and collaborations
CPHI will focus on key segments such as natural extracts, pharma excipients, finished dosage formulations, pharma ingredients, and fine chemicals. On the other hand, PMEC will highlight pharmaceutical machinery, packaging and drug delivery systems, clean technology, environmental protection, laboratory, analytical, and biotech equipment. This comprehensive approach will ensure a holistic experience for participants from every corner of the industry.
This year, the CPHI legacy brand celebrates its 35th anniversary as a global leader in uniting the pharmaceutical supply chain. For over three decades, the CPHI brand has connected the global pharma community, driving advancements that improve human health. This milestone year marks a celebration of the pharma professionals who have contributed to the success of CPHI events around the world.
Speaking on the announcement of the 17th edition of CPHI and P-MEC India show, Mr. Yogesh Mudras, Managing Director of Informa Markets in India, opined: “India’s pharmaceutical industry stands as a cornerstone of global healthcare, leading the world in vaccine production and generic medicines. With a 60% share of global vaccine output and a 20% share of generics, India not only meets 70% of WHO’s demand for crucial vaccines but also sets the benchmark for quality and affordability. As the ‘pharmacy of the world,’ we harness a robust network of over 10,500 manufacturing facilities and a highly skilled workforce, positioning ourselves as a key player in the international market. With 100% FDI allowed in greenfield and brownfield pharmaceuticals, our commitment to innovation and excellence paves the way for sustained growth and access to affordable healthcare solutions worldwide.
“We are thrilled to bring together the brightest minds in the pharmaceutical industry at CPHI & PMEC India 2024, where CPHI is the heart of pharma. As India and South Asia lead global pharmaceutical innovation, this expo will continue to be the ideal platform for fostering connections, driving business growth, and spearheading new initiatives,” he added.
The CPHI & PMEC India Expo remains at the heart of the pharmaceutical sector, uniting suppliers, innovators, and professionals from across the globe. Attendees will have the opportunity to meet thought leaders, source innovative solutions, and secure contracts that will shape the future of the industry. Notable exhibitors at CPHI this year include Dr. Reddy’s Laboratories Ltd, Biocon Ltd, Glenmark Lifesciences Ltd, Morepen Laboratories Ltd, Oceanic Pharmachem, Hetero Labs Limited, Lupin Ltd, Signet Excipients Pvt. Ltd, Aurobindo Pharma, Capsugel Healthcare Pvt. Ltd, Supriya Lifescience Ltd, SMS Pharmaceuticals Ltd, MSN Laboratories Pvt. Ltd, Sekhmet Pharmaventures Pvt. Ltd, Tirupati Lifesciences Pvt. Ltd, and Merck Lifesciences Pvt. Ltd.
On the PMEC side, exhibitors include prominent names like Accupack, Ace Technologies, ACG, Avishmachines Intertech, Cadmach, Fette, IMA PG, PARLE, Snowbell, Tofflon, Jicon, and Pacifab, showcasing cutting-edge machinery and technology for pharmaceutical manufacturing.
This year’s edition is set to attract participation from over 120 countries, including key markets such as the USA, UAE, South Korea, Japan, Egypt, Vietnam, the Philippines, Malaysia, Italy, Sri Lanka, Bangladesh, Nepal, Iran, and the United Kingdom. The event will also feature the Pharmaceutical Supply Chain Initiative (PSCI), further expanding its global reach and engagement.
To further amplify its impact, Informa Markets in India is organizing a series of roadshows across India in pharma hubs like Ahmedabad, Hyderabad and Mumbai with an aim to connect industry leaders, stakeholders, and small to mid-sized enterprises, fostering strategic partnerships and long-term business relationships.
The event will also feature significant onsite enhancements to elevate the attendee experience, with dedicated spaces like the Customer Insights Lounge, International Lounge, B2B Lounge, Sustainability Lounge, Conference Hall, and a fully-equipped Sales Office. Startups will have exclusive opportunities to accelerate their growth by tapping into funding avenues, mentorship programmes, and expansive industry networks through the Start Up Market, designed to foster innovation and collaboration.
In addition to the main exhibition, CPHI & PMEC India will host several initiatives during the prestigious India Pharma Week, creating a dynamic platform for informal networking and collaboration. Key events include:
The event is endorsed by prominent industry associations, including the Federation of Pharma Entrepreneurs (FOPE), Pharmaceutical Export Promotion Council (Pharmexcil), Organisation of Pharmaceutical Producers of India (OPPI), and Bulk Drug Manufacturers Association (BDMA). Their support solidifies CPHI & PMEC India as the premier meeting place for pharmaceutical business growth and networking.
Aligned with Informa Markets in India’s 5th Festivity of Business campaign, CPHI & PMEC India is part of a series of signature shows running from September to December. This campaign fosters connections, meaningful conversations, and business relationships that contribute to collective industry growth.
A Lean Approach, by Navdeep Singh Kathuria
To mitigate Regulatory Challenges in Aseptic Manufacturing, by Dr. Subrata Chakraborty
Thoughts on Sustainability Drives by Prabir K Das